BRIEF-Celadon Pharma announces Board changes and de-listing proposalMarch 24 (Reuters) - Celadon Pharmaceuticals PLC CEL.L:
CELADON PHARMA. PLC - BOARD CHANGES AND DE-LISTING PROPOSAL
CELADON PHARMACEUTICALS- ON MAR 19, CEO JAMES SHORT PROPOSES REMOVAL OF 4 NON-EXECUTIVE DIRECTORS & CHAIRMAN AS DIRECTORS
CELADON PHARMACEUTICALS PLC - ON MAR 21, FOUR NON-EXECUTIVE DIRECTORS RESIGN FROM CELADON BOARD
CELADON PHARMACEUTICALS PLC -FOLLOWING BOARD CHANGES, CO TO PROPOSE CANCELLATION OF TRADING ON AIM
Source text: ID:nRSX8322Ba
Further company coverage: CEL.L
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments